Serge Belanger
Stock Analyst at Needham
(4.70)
# 155
Out of 5,113 analysts
376
Total ratings
58.92%
Success rate
29.15%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Serge Belanger
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CYTK Cytokinetics | Reiterates: Buy | $72 | $62.72 | +14.80% | 25 | Dec 12, 2025 | |
| OCUL Ocular Therapeutix | Reiterates: Buy | $20 | $12.56 | +59.24% | 6 | Dec 8, 2025 | |
| KALV KalVista Pharmaceuticals | Reiterates: Buy | $28 | $15.23 | +83.85% | 22 | Dec 4, 2025 | |
| CRMD CorMedix | Maintains: Buy | $20 → $16 | $12.02 | +33.11% | 19 | Nov 12, 2025 | |
| OCS Oculis Holding AG | Reiterates: Buy | $36 | $21.25 | +69.41% | 2 | Nov 11, 2025 | |
| AMPH Amphastar Pharmaceuticals | Maintains: Buy | $36 → $34 | $26.60 | +27.82% | 8 | Nov 7, 2025 | |
| NAMS NewAmsterdam Pharma Company | Maintains: Buy | $40 → $46 | $35.11 | +31.02% | 10 | Nov 5, 2025 | |
| BCRX BioCryst Pharmaceuticals | Maintains: Buy | $20 → $18 | $7.41 | +142.91% | 18 | Nov 4, 2025 | |
| LQDA Liquidia | Maintains: Buy | $36 → $52 | $34.53 | +50.59% | 34 | Nov 4, 2025 | |
| XENE Xenon Pharmaceuticals | Reiterates: Buy | $55 | $44.10 | +24.72% | 13 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $30 | $28.01 | +7.10% | 23 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $46 | $48.88 | -5.89% | 26 | Oct 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $9.60 | - | 9 | Oct 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $66 → $20 | $13.39 | +49.37% | 14 | Sep 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $3 | $1.30 | +130.77% | 23 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $24 → $22 | $13.01 | +69.10% | 22 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $36 → $34 | $31.92 | +6.52% | 18 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $22 | $7.07 | +211.17% | 16 | Aug 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | n/a | $7.82 | - | 19 | May 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $30 | $26.35 | +13.85% | 28 | May 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $3.93 | +1.78% | 20 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.66 | - | 1 | Mar 31, 2022 |
Cytokinetics
Dec 12, 2025
Reiterates: Buy
Price Target: $72
Current: $62.72
Upside: +14.80%
Ocular Therapeutix
Dec 8, 2025
Reiterates: Buy
Price Target: $20
Current: $12.56
Upside: +59.24%
KalVista Pharmaceuticals
Dec 4, 2025
Reiterates: Buy
Price Target: $28
Current: $15.23
Upside: +83.85%
CorMedix
Nov 12, 2025
Maintains: Buy
Price Target: $20 → $16
Current: $12.02
Upside: +33.11%
Oculis Holding AG
Nov 11, 2025
Reiterates: Buy
Price Target: $36
Current: $21.25
Upside: +69.41%
Amphastar Pharmaceuticals
Nov 7, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $26.60
Upside: +27.82%
NewAmsterdam Pharma Company
Nov 5, 2025
Maintains: Buy
Price Target: $40 → $46
Current: $35.11
Upside: +31.02%
BioCryst Pharmaceuticals
Nov 4, 2025
Maintains: Buy
Price Target: $20 → $18
Current: $7.41
Upside: +142.91%
Liquidia
Nov 4, 2025
Maintains: Buy
Price Target: $36 → $52
Current: $34.53
Upside: +50.59%
Xenon Pharmaceuticals
Nov 4, 2025
Reiterates: Buy
Price Target: $55
Current: $44.10
Upside: +24.72%
Oct 28, 2025
Maintains: Buy
Price Target: $22 → $30
Current: $28.01
Upside: +7.10%
Oct 28, 2025
Reiterates: Buy
Price Target: $46
Current: $48.88
Upside: -5.89%
Oct 15, 2025
Reiterates: Hold
Price Target: n/a
Current: $9.60
Upside: -
Sep 30, 2025
Maintains: Buy
Price Target: $66 → $20
Current: $13.39
Upside: +49.37%
Aug 8, 2025
Maintains: Buy
Price Target: $4 → $3
Current: $1.30
Upside: +130.77%
Aug 8, 2025
Maintains: Buy
Price Target: $24 → $22
Current: $13.01
Upside: +69.10%
Aug 6, 2025
Maintains: Buy
Price Target: $36 → $34
Current: $31.92
Upside: +6.52%
Aug 6, 2025
Downgrades: Hold
Price Target: $22
Current: $7.07
Upside: +211.17%
May 14, 2025
Reiterates: Hold
Price Target: n/a
Current: $7.82
Upside: -
May 9, 2025
Maintains: Buy
Price Target: $32 → $30
Current: $26.35
Upside: +13.85%
May 7, 2025
Maintains: Buy
Price Target: $5 → $4
Current: $3.93
Upside: +1.78%
Mar 31, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.66
Upside: -